Slider Versus Tensioner Neural Mobilization Techniques in Carpal Tunnel Syndrome

November 15, 2026 updated by: Mohammad Moustafa Aldosoukki Hegazy, Prince Sattam Bin Abdulaziz University

Comparative Effects of Slider Versus Tensioner Median Nerve Mobilization in Patients With Carpal Tunnel Syndrome

neural mobilization techniques in carpal tunnel syndrome

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

Thirty patients with CTS will be randomly allocated to two equal groups of 15. Group A will receive slider median nerve mobilization techniques and Group B received tensioners median nerve mobilization techniques , twice a week for 10 weeks

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Clinical diagnosis of Alzheimer's Disease
  • Must be able to swallow tablets

Exclusion Criteria:

  • received physiotherapy or a steroid injection for CTS in the previous 3 months
  • have CTS secondary to a chronic systemic disease such as diabetes mellitus, hypothyroidism or rheumatoid arthritis
  • had previous wrist surgery
  • have cervical radiculopathy or severe polyneuropathy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: group A

slider median nerve mobilization tecnique

patients in group A recieve slider median nerve mobilization

Experimental: group b

tensioner median nerve mobilization techniques

patients in group recieve tensioner median nerve mobilization techniques

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
pain intensity
Time Frame: 10 weeks

pain intensity will be measured by visual analogue scale

10 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
functional disability
Time Frame: 10 weeks

it will be assessed by the arabic version of DASH questionnaire

10 weeks
hand grip strength
Time Frame: 10 WEEKS

it will be assessed by HHD

10 WEEKS
Pressure pain threshold
Time Frame: 10 weeks

It will be assessed by pressure algometry

10 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

December 5, 2026

Primary Completion (Estimated)

April 10, 2027

Study Completion (Estimated)

April 20, 2027

Study Registration Dates

First Submitted

November 9, 2026

First Submitted That Met QC Criteria

November 15, 2026

First Posted (Actual)

November 20, 2026

Study Record Updates

Last Update Posted (Actual)

November 20, 2026

Last Update Submitted That Met QC Criteria

November 15, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • RHPT/026/026

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.